Milk-derived bioactive peptides: From science to applications

被引:560
作者
Korhonen, Hannu [1 ]
机构
[1] MTT Biotechnol & Food Res, FIN-31600 Jokioinen, Finland
关键词
Milk proteins; Bioactive peptides; Production; Functionality; Applications; ENZYME-INHIBITORY PEPTIDES; NORMAL BLOOD-PRESSURE; LACTIC-ACID BACTERIA; VAL-PRO-PRO; FERMENTED MILK; SOUR MILK; ANTIHYPERTENSIVE PEPTIDES; CASEIN HYDROLYSATE; IN-VITRO; PROTEOLYTIC-ENZYMES;
D O I
10.1016/j.jff.2009.01.007
中图分类号
TS2 [食品工业];
学科分类号
100403 [营养与食品卫生学];
摘要
Milk proteins have received increasing attention as potential ingredients of health-promoting functional foods targeted at diet-related chronic diseases, such as cardiovascular disease, diabetes type two and obesity. To this end, growing interest has been focused on physiologically active peptides derived from milk proteins. These peptides are inactive within the sequence of the parent protein molecule and can be liberated by gastrointestinal digestion of milk, fermentation of milk with proteolytic starter cultures or hydrolysis by proteolytic enzymes. Milk protein-derived peptides have been shown under in vitro and in vivo conditions to exert a number of activities affecting the digestive, endocrine, cardiovascular, immune and nervous systems. A great variety of naturally formed bioactive peptides have been found in fermented dairy products, such as yoghurt, sour milk and cheese. Recently, industrial-scale technologies suitable for the industrial production of bioactive milk peptides have been developed. In addition, a few commercial food products supplemented with milk protein-derived bioactive peptides have been launched on limited markets. Some of these products carry clinically documented benefits, in particular for reduction of mild hypertension. The multifunctional properties of milk peptides appear to offer considerable potential for the development of many similar products in the near future. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:177 / 187
页数:11
相关论文
共 103 条
[1]
Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension [J].
Aihara, K ;
Kajimoto, O ;
Hirata, H ;
Takahashi, R ;
Nakamura, Y .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2005, 24 (04) :257-265
[2]
Identification of large phosphopeptides from β-casein that characteristically accumulate during ripening of the semi-hard cheese Herrgard [J].
Ardo, Y. ;
Lilbaek, H. ;
Kristiansen, K. R. ;
Zakora, M. ;
Otte, J. .
INTERNATIONAL DAIRY JOURNAL, 2007, 17 (05) :513-524
[3]
Ashar MN, 2004, MILCHWISSENSCHAFT, V59, P363
[4]
Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses [J].
Buetikofer, Ueli ;
Meyer, Jacques ;
Sieber, Robert ;
Wechsler, Daniel .
INTERNATIONAL DAIRY JOURNAL, 2007, 17 (08) :968-975
[5]
Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation [J].
Chen, Guan-Wen ;
Tsai, Jenn-Shou ;
Pan, Bonnie Sun .
INTERNATIONAL DAIRY JOURNAL, 2007, 17 (06) :641-647
[6]
Angiotensin I-converting-enzyme (ACE)-inhibitory activity of tryptic peptides of ovine β-lactoglobulin and of milk yoghurts obtained by using different starters [J].
Chobert, JM ;
El-Zahar, K ;
Sitohy, M ;
Dalgalarrondo, M ;
Métro, F ;
Choiset, Y ;
Haertlé, T .
LAIT, 2005, 85 (03) :141-152
[7]
Bioactive milk peptides: A prospectus [J].
Clare, DA ;
Swaisgood, HE .
JOURNAL OF DAIRY SCIENCE, 2000, 83 (06) :1187-1195
[8]
Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates [J].
da Costa, Elizabete Lourenco ;
da Rocha Gontijo, Jose Antonio ;
Netto, Flavia Maria .
INTERNATIONAL DAIRY JOURNAL, 2007, 17 (06) :632-640
[9]
Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk [J].
Donkor, Osaana N. ;
Henriksson, Anders ;
Vasiljevic, Todor ;
Shah, Nagendra P. .
LAIT, 2007, 87 (01) :21-38
[10]
Lactotripeptides show no effect on human blood pressure - Results from a double-blind randomized controlled trial [J].
Engberink, Marielle F. ;
Schouten, Evert G. ;
Kok, Frans J. ;
van Mierlo, Linda A. J. ;
Brouwer, Ingeborg A. ;
Geleijnse, Johanna M. .
HYPERTENSION, 2008, 51 (02) :399-405